Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions von Karam, A., Ledermann, J.A., Kim, J.-W., Sehouli, J., Lu, K., Gourley, C., Katsumata, N., Burger, R.A., Nam, B.-H., Bacon, M., Ng, C., Pfisterer, J., Bekkers, R.L.M., Casado Herráez, A., Redondo, A., Fujiwara, H., Gleeson, N., Rosengarten, O., Scambia, G., Zhu, J., Okamoto, A., Stuart, G., Ochiai, K.

Volltext

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial von Mirza, Mansoor R., Benigno, B., Dørum, A., Mahner, S., Bessette, P., Barceló, I. Bover, Berton-Rigaud, D., Ledermann, J.A., Rimel, B.J., Herrstedt, J., Lau, S., du Bois, A., Herráez, A. Casado, Kalbacher, E., Buscema, J., Lorusso, D., Vergote, I., Levy, T., Wang, P., de Jong, F.A., Gupta, D., Matulonis, U.A.

Volltext

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer von Makker, Vicky, Colombo, Nicoletta, Casado Herráez, Antonio, Santin, Alessandro D, Colomba, Emeline, Miller, David S, Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally, Ray-Coquard, Isabelle, Shapira-Frommer, Ronnie, Ushijima, Kimio, Sakata, Jun, Yonemori, Kan, Kim, Yong Man, Guerra, Eva M, Sanli, Ulus A, McCormack, Mary M, Smith, Alan D, Keefe, Stephen, Bird, Steven, Dutta, Lea, Orlowski, Robert J, Lorusso, Domenica

Volltext

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020) von de Juan Ferré, A., Álvarez Álvarez, R., Casado Herráez, A., Cruz Jurado, J., Estival González, A., Martín-Broto, J., Martínez Marín, V., Moreno Vega, A., Sebio García, A., Valverde Morales, C.

Volltext

Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions von Sanchez-Morillas, L., Casado Herraez, A., Rubio-Perez, M., Robledo Echarren, T., Gonzalez Gutierrez, M. L., Cimarra, M., Vazquez Cortes, S., Cerecedo, Fernandez-Rivas, M.

Volltext

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-cont... von Ledermann, J.A., Zurawski, B., Raspagliesi, F., De Giorgi, U., Arranz Arija, J., Romeo Marin, M., Lisyanskaya, A., Póka, R.L., Markowska, J., Cebotaru, C., Casado Herraez, A., Colombo, N., Kutarska, E., Hall, M., Jacobs, A., Ahrens-Fath, I., Baumeister, H., Zurlo, A., Sehouli, J.

Volltext

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life von Brotto, Lori, Brundage, Michael, Hoskins, Paul, Vergote, Ignace, Cervantes, Andres, Casado, Herraez A., Poveda, A., Eisenhauer, Elizabeth, Tu, Dongsheng

Volltext

726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-... von Colombo, N., Lorusso, D., Herráez, A. Casado, Santin, A.D., Colomba, E., Miller, D.S., Fujiwara, K., Pignata, S., Floquet, A., Monk, B.J., Banerjee, S., Penson, R.T., Kristeleit, R., Fabbro, M., Orlando, M., Mackay, H., Jensen, E., Dutta, L., Orlowski, R., Makker, V.

Volltext

A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall von Bonvalot, S., Rutkowski, P.L., Thariat, J., Carrere, S., Sunyach, M.-P., Saada, E., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., Le Pechoux, C., Moreno, V., Li, R., Tiangco, B., Casado Herraez, A., Gronchi, A., Mangel, L., Hohenberger, P., Delannes, M., Papai, Z.

Volltext

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference von Bookman, M A, Okamoto, A, Stuart, G, Yanaihara, N, Aoki, D, Bacon, M, Fujiwara, K, González-Martín, A, Harter, P, Kim, J W, Ledermann, J, Pujade-Lauraine, E, Quinn, M, Ochiai, K

Volltext

Treatment guidelines in ovarian cancer von Poveda Velasco, A, Casado Herráez, A, Cervantes Ruipérez, A, Gallardo Rincón, D, García García, E, González Martín, A, López García, G, Mendiola Fernández, C, Ojeda González, B

Volltext

Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA tria... von Matulonis, U.A., Walder, L., Nøttrup, T.J., Tinker, A.V., Mahner, S., Gil-Martin, M., Fabbro, M., Banerjee, S., Wenham, R.M., Woie, K., Gilbert, L., Harter, P., Herráez, A. Casado, Follana, P., Ledermann, J.A., Leroy, C., Scollo, P., Lund, B., Malander, S., Fisher, M., Guy, H., Mirza, M.R.

Volltext

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial von Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, O'Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A, Buck, M, Dean, A, Friedlander, M L, Harnett, P, Scott, C L, Dirix, L, Vergote, I, Elit, L, Ghatage, P, Oza, A M, Plante, M, Provencher, D, Weberpals, J I, Floquet, A, Joly, F, Leary, A, Medioni, J, Tredan, O, You, B, El-Balat, A, Hänle, C, Krabisch, P, Neunhöffer, T, Pölcher, M, Wimberger, P, Amit, A, Kovel, S, Leviov, M, Safra, T, Shapira-Frommer, R, Stemmer, S, Bologna, A, Colombo, N, Lorusso, D, Sabbatini, R F, Scambia, G, Tamberi, S, Zamagni, C, Fong, P C, O'Donnell, A, Gancedo, M Amenedo, Garcia-Donas, J, Guerra, E M, Oaknin, A, Palacio, I, Romero, I, Sanchez, A, Banerjee, S N, Drew, Y, Jackson, D, Ledermann, J A, McNeish, I A, Parkinson, C, Powell, M, Buss, M K, Chambers, S K, Chen, L-m, Coleman, R L, Holloway, R W, Konecny, G E, Ma, L, Morgan, M A, Morris, R T, O'Malley, D M, Slomovitz, B M, Swisher, E M, Vanderkwaak, T, Vulfovich, M

Volltext

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

1780P Homologous recombination pathway in sarcomas: A novel opportunity of therapy? von Garijo Martínez, M.D.C., Amann Arevalo, M., Manzano Fernández, A., Casado Herraez, A., Marquina Ospina, G., Pérez Segura, P., Fernandez, L., Ortega, L., Lopez Mateos, Y., Benitez Fuentes, J.D., Morchón Araujo, D., Roldan Ruiz, J., Bartolomé Arcilla, J.

Volltext

1926P Trabectedin plus radiotherapy on symptomatic advanced sarcoma patients: Results from the SYNERGIAS study - A Spanish group for research in sarcoma (GEIS) phase II study von Martin-Broto, J., Kopeckova, K., Azinovic, I., Jurado, J. Cruz, Guzmán, L., Alvarez, R.M., Herraez, A. Casado, Morales, C.M. Valverde, Sanchez, A. Redondo, Lleida, R. Teres, Gonzalez, A. Alvarez, Dolado, M.C., Doval, A., Belinchón, B., Merino, J.A., Mendez, R., Ledesma, P., Gutierrez, A., Da Silva Moura, D., Hindi Muñiz, N.

Volltext

LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in rec... von Banerjee, S., Ottevanger, P.B., Sarivalasis, A., Le Scodan, R., Montes, A., Kroep, J.R., Romeo Marin, M., Casado Herraez, A., Auvray-Kuentz, M., Westermann, A.M., Lucas, B., Dangaj, D., Herrera, F., Wolfer, A., Coens, C., Vanlancker, M.B., Kandalaft, L., Coukos, G.

Volltext

525MO Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): St... von Makker, V., Colombo, N., Casado Herraez, A., Monk, B.J., Mackay, H., Santin, A.D., Miller, D.S., Moore, R.G., Baron-Hay, S.E., Ray-Coquard, I.L., Shapira-Frommer, R., Ushijima, K., Yonemori, K., Kim, Y.M., Guerra Alia, E.M., Sanli, U.A., Huang, J., McKenzie, J., Barresi, G., Lorusso, D.

Volltext

1509P Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion von Blay, J-Y., Gelderblom, H., Rutkowski, P., Wagner, A., van de Sande, M., Falcon Gonzalez, A., Stacchiotti, S., Le Cesne, A., Alcindor, T., Serrano, C., Palmerini, E., Ravi, V., Casado Herraez, A., Seddon, B., Vallee, M., Jarecha, R., Sharma, M., Ruiz-Soto, R., Sherman, M.L., Tap, W.D.

Volltext

20MO Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician’s... von Lorusso, D., Colombo, N., Casado Herraez, A., Santin, A.D., Colomba, E., Miller, D.S., Fujiwara, K., Pignata, S., Baron-Hay, S.E., Ray-Coquard, I.L., Shapira-Frommer, R., Kim, Y.M., McCormack, M., Massaad, R., Martin Nguyen, A., Zhao, Q., McKenzie, J., Prabhu, V.S., Makker, V.

Volltext